Search Press releases Keywords From To 12 Jun 2024 UCB to share first presentations of BIMZELX[®]▼ (bimekizumab) two-year data in axial spondyloarthritis and psoriatic arthritis at EULAR 2024 Read More 10 Jun 2024 Global experts release new guidelines on prevention of progression of epileptic seizures, addressing critical treatment gaps Read More 7 Jun 2024 Acquisition of own shares Read More 31 May 2024 Acquisition of own shares Read More 31 May 2024 UCB announces positive CHMP opinion for 320 mg device presentations of BIMZELX[®]▼ (bimekizumab) Read More 24 May 2024 Acquisition of own shares Read More Pagination First page Previous page Previous … Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Page 14 Page 15 Page 16 … Page 12 of 66 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
